Book contents
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- 121 Actinomycosis
- 122 Anaerobic Infections
- 123 Anthrax and Other Bacillus Species
- 124 Bartonellosis (Carrión's Disease)
- 125 Cat Scratch Disease and Other Bartonella Infections
- 126 Bordetella
- 127 Moraxella (Branhamella) Catarrhalis
- 128 Brucellosis
- 129 Campylobacter
- 130 Clostridia
- 131 Corynebacteria
- 132 Enterobacteriaceae
- 133 Enterococcus
- 134 Erysipelothrix
- 135 HACEK
- 136 Helicobacter Pylori
- 137 Gonococcus: Neisseria Gonorrhoeae
- 138 Haemophilus
- 139 Legionellosis
- 140 Leprosy
- 141 Meningococcus and Miscellaneous Neisseriae
- 142 Listeria
- 143 Nocardia
- 144 Pasteurella Multocida
- 145 Pneumococcus
- 146 Pseudomonas, Stenotrophomonas, and Burkholderia
- 147 Rat-Bite Fevers
- 148 Salmonella
- 149 Staphylococcus
- 150 Streptococcus Groups A, B, C, D, and G
- 151 Viridans Streptococci
- 152 Poststreptococcal Immunologic Complications
- 153 Shigella
- 154 Tularemia
- 155 Tuberculosis
- 156 Nontuberculous Mycobacteria
- 157 Vibrios
- 158 Yersinia
- 159 Miscellaneous Gram-Positive Organisms
- 160 Miscellaneous Gram-Negative Organisms
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- Part XXV Antimicrobial Therapy – General Considerations
- Index
123 - Anthrax and Other Bacillus Species
from Part XVIII - Specific Organisms – Bacteria
Published online by Cambridge University Press: 05 March 2013
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- 121 Actinomycosis
- 122 Anaerobic Infections
- 123 Anthrax and Other Bacillus Species
- 124 Bartonellosis (Carrión's Disease)
- 125 Cat Scratch Disease and Other Bartonella Infections
- 126 Bordetella
- 127 Moraxella (Branhamella) Catarrhalis
- 128 Brucellosis
- 129 Campylobacter
- 130 Clostridia
- 131 Corynebacteria
- 132 Enterobacteriaceae
- 133 Enterococcus
- 134 Erysipelothrix
- 135 HACEK
- 136 Helicobacter Pylori
- 137 Gonococcus: Neisseria Gonorrhoeae
- 138 Haemophilus
- 139 Legionellosis
- 140 Leprosy
- 141 Meningococcus and Miscellaneous Neisseriae
- 142 Listeria
- 143 Nocardia
- 144 Pasteurella Multocida
- 145 Pneumococcus
- 146 Pseudomonas, Stenotrophomonas, and Burkholderia
- 147 Rat-Bite Fevers
- 148 Salmonella
- 149 Staphylococcus
- 150 Streptococcus Groups A, B, C, D, and G
- 151 Viridans Streptococci
- 152 Poststreptococcal Immunologic Complications
- 153 Shigella
- 154 Tularemia
- 155 Tuberculosis
- 156 Nontuberculous Mycobacteria
- 157 Vibrios
- 158 Yersinia
- 159 Miscellaneous Gram-Positive Organisms
- 160 Miscellaneous Gram-Negative Organisms
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- Part XXV Antimicrobial Therapy – General Considerations
- Index
Summary
Anthrax is primarily a disease of grazing domestic animals. It is an acute disease caused by the spore-forming, gram-positive, nonmotile, toxin-producing aerobic rod Bacillus anthracis. It is the oldest known zoonosis with worldwide distribution: rare and sporadic and almost dis-appearing in the United States and in central and northern Europe, moderately common in southern Europe, and common in the former Soviet Union, in tropical and subtropical Africa, Asia, the Caribbean, and South America. The most affected countries are Turkey, Afghanistan, Iran, Pakistan, the Central Asian republics of the former Soviet Union, and sub-Saharan and South Africa. The incidence of human anthrax has decreased considerably in all countries since the introduction of an effective vaccine for use in animals. The frequency of infections in humans depends on the prevalence of the disease in livestock, which increases in years of drought.
EPIDEMIOLOGY
The ability to form spores permits the organism to survive environmental and disinfective measures that destroy most other bacteria. Public health problems largely arise from its long persistence in the soil (up to 90 years). In the Anglo-American biologic warfare experiments conducted in 1942 to 1943 on the uninhabited island of Gruinard off the western coast of Scotland, an estimated 4 × 1014 spores were exploded over the surface. Animal tests for more than 20 years demonstrated the persistence of virulent spores, eventually eliminated by disinfection of the area with a mixture of formaldehyde and sea water.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 897 - 902Publisher: Cambridge University PressPrint publication year: 2008